Owens & Minor Sells P&HS Segment for $375m, Focusing on Home-Based Care Operations
ByAinvest
Thursday, Oct 9, 2025 9:50 am ET1min read
OMI--
The strategic divestiture supports Owens & Minor’s transformation into a pure-play home-based care platform, centered around its Patient Direct business [1]. The company plans to use the net proceeds from the sale to reduce its outstanding debt, which currently stands at $1.9 billion. This move is part of the company's broader initiative to strengthen its balance sheet and accelerate growth in its Patient Direct segment [2].
Platinum Equity, a global investment firm with a strong track record in healthcare and supply chain operations, expressed confidence in the future of the P&HS business. The firm plans to grow the segment as a standalone company and support its operational transformation [3].
The transaction is subject to customary closing conditions, including regulatory approvals under the Hart-Scott-Rodino Antitrust Improvements Act. Owens & Minor expects the sale to close by the end of the year [1].
Owens & Minor has agreed to sell its Products & Healthcare Services (P&HS) segment to Platinum Equity for $375m. The company will retain a 5% equity stake in the business and preserve over $150m in tax attributes. The transaction enables Owens & Minor to focus on home-based care operations, aligning with its strategic shift over recent years. The deal is expected to close by the end of the year, subject to regulatory review and customary closing conditions.
Richmond, Va. — Owens & Minor, a prominent healthcare services provider, has agreed to sell its Products & Healthcare Services (P&HS) segment to Platinum Equity for $375 million in cash. The transaction includes a 5% equity stake in the business for Owens & Minor, which also retains over $150 million in tax assets. The sale aligns with Owens & Minor's strategic shift towards home-based care, as it focuses on its Patient Direct business.The strategic divestiture supports Owens & Minor’s transformation into a pure-play home-based care platform, centered around its Patient Direct business [1]. The company plans to use the net proceeds from the sale to reduce its outstanding debt, which currently stands at $1.9 billion. This move is part of the company's broader initiative to strengthen its balance sheet and accelerate growth in its Patient Direct segment [2].
Platinum Equity, a global investment firm with a strong track record in healthcare and supply chain operations, expressed confidence in the future of the P&HS business. The firm plans to grow the segment as a standalone company and support its operational transformation [3].
The transaction is subject to customary closing conditions, including regulatory approvals under the Hart-Scott-Rodino Antitrust Improvements Act. Owens & Minor expects the sale to close by the end of the year [1].

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet